It's never too early to get the speculation started for the

New Post Public Reply Private Reply Replies (2) Message Board
hoops
409
It's never too early to get the speculation started for the new year. I know this (below) was posted earlier, but I didn't realize it was from the Motley Fool. I'm not sure if they are blowing smoke, or actually believe this.

I have followed and been invested in GW Phar. (GWPH) for more than a year. IMO, GWPH is the best all around medical cannabis investment. It is an English company that is well-financed. It's childhood epilepsy drug, Epediolex, has been approved by the FDA. My understanding is that Epediolex is derived from one cannabis molecule. GWPH's research will focus on other molecules to address other conditions. When MF states that Kali and GNBT present competition to GWPH, that's heady stuff. I hope it's true

"New York, NY -- December 24, 2018 -- InvestorsHub NewsWire -- via nextbigticker.com -- Kali, Inc. (dba/Kali-Extracts) (USOTC: KALY) and Generex Biotechnology Corp (OTCQB: GNBT) through a deal announced between GNBT and US Cannabis Health, a Joint Venture partnership between KALY and Puration, Inc. (USOTC: PURA) and Nouveau Life Pharmaceuticals (USOTC: NOUV) could potentially soon introduce a cannabis drug that not only rivals GW Pharmaceuticals’ (NASDAQ: GWPH) Epidiolex, KALY and GNBT’s cannabis drug development could reveal that GWPH’s Epidiolex infringes on GNBT patents.

"I believe the underlying value of Kali-Extracts cannabis biotechnology properties are as of yet unrecognized by the market," said Frederick Ferri, CEO of Kali-Extracts. "Doctors involved in research with our extracts have given me feedback that our extracts are superior to those of GW Pharmaceuticals [GW Pharmaceuticals, plc (GWPH)]. As just one example of what our cannabis biotechnology can lead to, I believe our developing COPD therapies in combination with the potential for us to harness the patented RapidMist buccal cavity drug administration technology of Generex [Generex Biotechnology, Corp. (GNBT)] through our US Cannabis Health partnership, would put Kali-Extracts in front of any cannabis biotechnology company on the market. For that matter, I think Generex applying its patented RapidMist buccal cavity administration technology would bode well for Generex as well. I also happen to think that the combination of our COPD technology with the RapidMist technology of Generex would illustrate that GW Pharmaceuticals buccal drug administration is likely an infringement on Generex's RapidMist patent. In summary, the market has a lot yet to learn about Kali-extracts cannabis biotechnology. I hope the COPD example herein begins to give a glimpse of that yet to be realized value. Finally, I think the developing partnership between KALY and its other US Cannabis Health partners with Generex can put KALY, its other US Cannabis Health partners and Generex on top of their respective markets." (source - yahoo.com)

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LifeVac's 7,000 Reported Saves Deserve Careful Context

Updated Category News Views 99

Veggie straws are supposed to be harmless until they are not. LifeVac says a 19-month-old girl in South Dakota became unable to breathe on November 14 after eating the snack, with a sticky piece creating a complete airway obstruction. Her father retrieved the family's LifeVac, used the pediatric mask while she was on her back, and the company says one application...

Continue Reading
Fuel Cell Market Faces Uneven Growth Amid Revenue Shifts

Updated Category News Views 152

Fuel Cell Sector Eyes Mixed Results and Big Projections The fuel cell market, oh what a beast it's becoming—a story filled with ups and downs, and more forecasts than a weather station. As we stand, this sector is poised to balloon to an $18.16 billion market by 2030. That's a growth rate of 26.3% annually, folks. These projections are driving excitement, but the...

Continue Reading
Grupo Supervielle's Q3 2026: Back to Growth Path

Updated Category News Views 66

Mounting Momentum in Loans and Asset Quality Grupo Supervielle, the Argentine financial player, has been tinkering with its gears to navigate the bumpy roads of 2026. In the third quarter, the company reports a gentle uptick in net loans—up 1.3% sequentially. This was particularly felt in September, with loans increasing 3.7%. Holding Their Own Against the Industry...

Continue Reading
Universal Haptics Protocol May Cut Integration Friction

Updated Category News Views 245

A controller rumbling at the wrong moment is a small annoyance, but the plumbing behind that rumble has been a stubborn mess for years. The Haptics Industry Forum's Universal Haptics Protocol 1.0, announced November 17, 2026, is an attempt to clean up that mess with a shared language between software and touch-feedback hardware. This is not the sort of release that sends...

Continue Reading
Stand Out For Good Makes a Bold Michigan Avenue Bet

Updated Category News Views 95

A six-floor retail commitment lands with a thud Stand Out For Good is taking on roughly 51,079 square feet at 669 North Michigan Avenue, and nobody should mistake that for a casual expansion. Six levels on Chicago's Magnificent Mile is a proper declaration of intent, especially in a retail district that has endured plenty of empty-window handwringing and big-brand churn....

Continue Reading
Animal Parasite Market Growth Has a Resistance Catch

Updated Category News Views 114

Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...

Continue Reading
PSEG Declares $0.67 Fourth-Quarter 2026 Cash Dividend

Updated Category News Views 44

A 67-cent utility dividend rarely sets the tape on fire, and that is precisely the point. Public Service Enterprise Group declared a regular fourth-quarter 2026 common-stock dividend of $0.67 per share, payable on or before December 31 to shareholders of record on December 10. For owners of NYSE:PEG, this is the sort of announcement that belongs in the “steady as she...

Continue Reading
Sharon Stuart's Quest for Her Hidden Origins

Updated Category News Views 123

Delving Into Identity: A Personal Odyssey In a world where everyone seems to be searching for something, Sharon Stuart's quest is etched with the raw need to uncover her real origins. Abandoned as a newborn in the gritty streets of Oakland, she grew up grappling with looming questions about what made her who she is. Her journey is captured in her memoir, "Existing Without...

Continue Reading
Toledo Crosswalk Death Lawsuit Raises Hard Questions

Updated Category News Views 154

A painted crosswalk is supposed to mean something, and that is the grim center of the lawsuit filed over Judy Tanner’s death in Toledo. Tanner, 20, was walking home from work on September 10, 2026, when she was struck and killed while crossing the street. Her estate is now suing, alleging that the 31-year-old driver failed to yield as Tanner legally used the crosswalk....

Continue Reading
Greenberg Traurig Cheers Clients' 69th GRAMMY® Nods

Updated Category News Views 130

A Momentous Occasion for Greenberg Traurig's Entertainment Clients Oh, the glamour and glitz of the music world! There's nothing quite like the GRAMMY® Awards to stir up a blend of excitement, ego, and anxiety in the industry. This time around, the lawyers over at Greenberg Traurig are beaming with pride as their clients scoop up nominations for the 69th Annual GRAMMY®...

Continue Reading

Top 5 Most Recently Viewed Articles

Dr. Moumine Ballo: Trailblazer in Electronics and Graphics

Updated Category News Views 256

Acknowledging Dr. Moumine Ballo's Influence in Technology Dr. Moumine Ballo has recently been honored as a Pinnacle Professional Member Inner Circle of Excellence, a testimony to his exceptional contributions in the fields of Computer Graphics and Electronics Engineering. With over three decades of experience, Dr. Ballo's impact in technology is both profound and...

Continue Reading
SolePursuit Capital Syndicate's Commitment to Governance Growth

Updated Category News Views 190

Introduction to Governance and Transparency Updates SolePursuit Capital Syndicate has taken significant strides in enhancing its governance framework and transparency protocols. Under the leadership of founder Laurence Kingsley, the organization recently shared its Annual Governance and Transparency Update. This document sheds light on the important advancements made in...

Continue Reading
Omni Family Institute's Program Achieves Major Regulatory Recognition

Updated Category News Views 228

Omni Family Institute Celebrates Program Recognition Omni Family Institute, a respected organization committed to trauma-informed care, proudly announces the recent acknowledgment of its flagship initiative, Together Facing the Challenge. This program has successfully achieved a 'Supported' rating from the Title IV-E Prevention Services Clearinghouse, a notable milestone...

Continue Reading
Ideal Power's Q3 2025 Financial Updates and Future Plans

Updated Category News Views 185

Company Overview Ideal Power Inc. (NASDAQ: IPWR) is a pioneering developer and provider of innovative semiconductor solutions, specializing in the B-TRAN® bidirectional power switch technology. This technology enhances energy efficiency across various applications, including electric vehicles and renewable energy. Milestone Achievements Recently, CEO David Somo expressed...

Continue Reading
Latest Developments Surrounding Meta Platforms Insider Trading

Updated Category News Views 409

Significant Insider Trading at Meta Platforms Meta Platforms, Inc. (NASDAQ: META) has recently caught attention due to a notable action taken by its Chief Product Officer, Christopher K. Cox. It has come to light that Cox sold a substantial 20,000 shares of the company’s Class A Common Stock. This transaction, occurring at a price range of $555.00 to $560.25 per share,...

Continue Reading